Cilia Disorders in the Genomics Era: A Narrative Review on the Impact of Next Generation Sequencing on Ciliopathy Diagnostics

Introduction: Motile and sensory (primary) cilia are organelles that are found on the surface of almost all cells. Defects in cilia cause a number of multi organ diseases known as ciliopathies, which have clinically heterogeneous symptoms. This heterogeneity makes diagnosing cilia disorders challenging and clinicians often rely on genetic sequencing to delineate ciliopathies from other diseases. However, there is not a consensus on which sequencing tools are most optimal for ciliopathy diagnosis and research.

Methods: Here I review the implications of next generation sequencing tools for ciliopathy diagnostics. I describe landmark studies that showed ciliopathies as genetic conditions and transition to the advantages and challenges of using next generation sequencing techniques. In particular, I compare studies that utilized targeted sequencing with those that used whole exome and/or whole genome sequencing.

Discussion: High throughput screens can identify novel cilia genes and show promise as a robust diagnostic tool in clinical settings. Moreover, I compare the effectiveness of whole exome and whole genome sequencing both for basic science research and clinical applications, arguing that whole exome sequencing is a sufficient first pass in clinical settings. I also acknowledge that ciliopathies are associated with many, both significant and unsignificant, genetic variants making interpreting next generation sequencing data an ongoing challenge for scientists and clinicians.

Conclusion: This review demonstrates the increasing body of knowledge on cilia genomics and highlights that next generation sequencing will be integral towards optimizing diagnostics for these heterogeneous and debilitating group of disorders.